San Diego company’s test to detect pancreatic cancer in early stages moves to human trials

  • 📰 sdut
  • ⏱ Reading Time:
  • 28 sec. here
  • 2 min. at publisher
  • 📊 Quality Score:
  • News: 15%
  • Publisher: 95%

대한민국 뉴스 뉴스

대한민국 최근 뉴스,대한민국 헤드 라인

Biological Dynamics spent more than a decade validating cancer diagnostic process spun out of UC San Diego and now has launched a study for people at high risk of pancreatic cancer

For more than a decade, Biological Dynamics has been working on technology licensed out of UC San Diego to enable early detection of diseases ranging from cancer to tuberculous to Alzheimer’s.

Founded in 2009, Biological Dynamics has developed proprietary technology that repels red blood cells and platelets to exclusively isolate exosomes — which are tiny structures inside a cell that contain some of the cell’s proteins, DNA and RNA. The lab-on-a-chip then detects the concentration of a handful of individual bio-markers specific to pancreatic cancer.

The company has raised $125 million since its founding to refine the technology. Biological Dynamics has 49 patents either granted or pending around its UCSD technology license.

 

귀하의 의견에 감사드립니다. 귀하의 의견은 검토 후 게시됩니다.
이 소식을 빠르게 읽을 수 있도록 요약했습니다. 뉴스에 관심이 있으시면 여기에서 전문을 읽으실 수 있습니다. 더 많은 것을 읽으십시오:

 /  🏆 5. in KR

대한민국 최근 뉴스, 대한민국 헤드 라인